TABLE 1.
Differences in the medium cholesterol collected from ABCG1 positive and negative BHK cells incubated with HDL3 (25 μg/ml)
| 8 h
|
18 h
|
|||
|---|---|---|---|---|
| Untreated | Mifepristone | Untreated | Mifepristone | |
| Media FC (μg/well, n = 9)a | 1.30 ± 0.10 | 1.80 ± 0.11 | 1.49 ± 0.07 | 2.15 ± 0.09 |
| Media cpm/well (×103, n = 3)a | 42.75 ± 0.57 | 76.50 ± 1.66 | 71.01 ± 2.22 | 116.18 ± 1.22 |
| % Eflux/well (n = 3)a | 3.84 ± 0.05 | 7.35 ± 0.17 | 6.05 ± 0.21 | 11.11 ± 0.12 |
BHK cells transfected with ABCG1 were labeled with [3H] free cholesterol in 10% FBS for 24 h and upregulated with or without 10 nM mifepristone for 18 h. The cells were then incubated with HDL3 (25 μg/ml) for 8 h and 18 h, and the media were collected for measuring the radioactivity and FC mass. Statistical significance (P < 0.05) was assessed between the untreated and mifepristone-treated (ABCG1) cells at each incubation time point.
P < 0.0001 between the medium of untreated and mifepristone-treated cells at 8 h and 18 h incubation period.